Shandong Wohua Pharmaceutical Co., Ltd.

002107

CNE000001QB8

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 10/05/2024 am IST			5-day change	1st Jan Change
4.99 ^CNY	-1.77%		+3.53%	-17.79%

26/04	Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
01/04	Shandong Wohua Pharmaceutical Co., Ltd. Proposes Profit Distribution for 2023	CI

Shandong Wohua Pharmaceutical Co., Ltd. Proposes Profit Distribution for 2023

April 02, 2024 at 01:03 am IST

Shandong Wohua Pharmaceutical Co., Ltd. announced on 1 April 2024 the profit distribution proposal for 2023 as follows: Cash dividend per 10 shares (tax included): CNY 2.50000000.

Latest news about Shandong Wohua Pharmaceutical Co., Ltd.

Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04	CI
Shandong Wohua Pharmaceutical Co., Ltd. Proposes Profit Distribution for 2023	02/04	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/23/26	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/23/28	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/23/26	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/22/27	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	15/22/15	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	15/22/15	CI
Wohua Pharmaceutical Sets Payment Date For 2021 Final Dividend	02/22/02	MT
Shandong Wohua Pharmaceutical Co., Ltd. Approves Dividend for the Year 2021, Payable on March 8, 2022	12/22/12	CI
Shandong Wohua Pharmaceutical Co., Ltd. Announces Executive Appointments	12/22/12	CI
Wohua Pharmaceutical Declares Final 2021 Dividend	24/22/24	MT
Shandong Wohua Pharmaceutical Co., Ltd. Proposes Dividend for the Year 2021	22/22/22	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	20/22/20	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	28/21/28	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	29/21/29	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	06/21/06	CI
Shandong Wohua Pharmaceutical Co., Ltd. Declares Cash Dividend for A Shares for 2020, Payable on 09 April 2021	01/21/01	CI
Beijing Tongfengtang Pharmaceutical Management Co., Ltd. cancelled the acquisition of Wohua Pharmaceutical International Co., Ltd. from Shandong Wohua Pharmaceutical Co., Ltd..	27/21/27	CI
Shandong Wohua Pharmaceutical Co., Ltd. Approves Distribution for 2020	23/21/23	CI
Shandong Wohua Pharmaceutical : Pharma Declares Cash Dividend	22/21/22	MT
Shandong Wohua Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2020	22/21/22	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	20/21/20	CI
Shandong Wohua Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	15/20/15	CI

Chart Shandong Wohua Pharmaceutical Co., Ltd.

Duration

Period

Chart Shandong Wohua Pharmaceutical Co., Ltd.

More charts

Shandong Wohua Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, production and distribution of Chinese traditional patent medicines. The Company's main products consist of Xinkeshu tablets for the treatment of coronary heart disease; Gushu tablets for the treatment of middle-aged and senile osteoporosis, and Hedan tablets for promoting blood circulation and for the treatment of hyperlipidemia. The Company distributes its products in domestic market, mainly in East China, North China and Northeast China.

Sector

Pharmaceuticals

Calendar

15/05/2024 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
SHANDONG WOHUA PHARMACEUTICAL CO., LTD.	-17.79%	406M
DONG-E-E-JIAO CO.,LTD.	+40.09%	6.3B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-16.34%	4.53B
TASLY PHARMACEUTICAL GROUP CO., LTD	-7.11%	3.29B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+5.14%	3.2B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-0.18%	2.63B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+47.93%	1.97B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.15%	1.74B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.67%	1.69B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-8.73%	1.64B

Alternative Medicine